000 01079 a2200301 4500
005 20250516215011.0
264 0 _c20140912
008 201409s 0 0 eng d
022 _a1096-9098
024 7 _a10.1002/jso.23648
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDonahue, James M
245 0 0 _aRole of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer.
_h[electronic resource]
260 _bJournal of surgical oncology
_cAug 2014
300 _a97-8 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAdenocarcinoma
_xdiagnosis
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdiagnosis
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdiagnosis
650 0 4 _aNeoplasm Staging
650 0 4 _aPrognosis
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
773 0 _tJournal of surgical oncology
_gvol. 110
_gno. 2
_gp. 97-8
856 4 0 _uhttps://doi.org/10.1002/jso.23648
_zAvailable from publisher's website
999 _c23886326
_d23886326